NeoGenomics, Inc. ã¯ãç±³åœããšãŒããããã¢ãžã¢ã§ããã«ç¹åããæ€æ»ã©ãã®ãããã¯ãŒã¯ãéå¶ããŠããŸããå瀟ã¯ãèšåºãµãŒãã¹ãšè£œè¬ãµãŒãã¹ã® 2 ã€ã®ã»ã°ã¡ã³ãã§äºæ¥ãå±éããŠããŸããå瀟ã¯ãç
é¢ããªãã¡ã¬ã³ã¹ ã©ããç
çåŠè
ãè
«çåŠè
ãèšåºå»ã補è¬äŒç€Ÿãç ç©¶è
ã«æ€æ»ãµãŒãã¹ãæäŸããŠããŸããå瀟ã¯ãæ£åžžããã³ç°åžžãªæè²äœãšãããã®çŸæ£ãšã®é¢ä¿ãç ç©¶ããããã®çްèéºäŒåŠæ€æ»ãµãŒãã¹ãæè²äœäžã®ç¹å®ã® DNA é
åããã³éºäŒåã®æç¡ã®æ€åºãšäœçœ®ç¹å®ã«éç¹ã眮ããèå
in situ ãã€ããªãã€ãŒãŒã·ã§ã³æ€æ»ãµãŒãã¹ã现èéå£ã®ç¹æ§ã枬å®ãããã㌠ãµã€ãã¡ããªãŒæ€æ»ãµãŒãã¹ãçµç¹åçå
ã®çްèã¿ã³ãã¯è³ªã®äœçœ®ãç¹å®ããã¯ã©ã€ã¢ã³ããã¹ãã£ã³ããã¹ã©ã€ããèŠèŠåããããŸããŸãªæè²ã®å®éåæãå®è¡ã§ããããã«ããå
ç«çµç¹ååŠããã³ããžã¿ã«ç»åæ€æ»ãµãŒãã¹ãæäŸããŠããŸããå瀟ã¯ãŸããDNA ã RNA ã®åæãããã³ååã¬ãã«ã§ã®éºäŒåã®æ§é ãšæ©èœã«éç¹ã眮ããå忀æ»ãµãŒãã¹ãæäŸããŠããŸããå瀟ã¯ã蚺æãç®çãšããŠç
çåŠè
ãé¡åŸ®é¡äžã§çްèãåæããããã»ã¹ã§ãã圢æ
åŠçåæãããã³çºèŠãšåååãå«ã補è¬äŒç€Ÿã®ã¯ã©ã€ã¢ã³ãã®è
«çåŠããã°ã©ã ããµããŒãããæ€æ»ãµãŒãã¹ããªãã³ã«è§£åç
çåŠæ€æ»ãµãŒãã¹ãæäŸããåç
§ã©ããšããŠã®åœ¹å²ãæãããŠããŸããå瀟㯠Inivata Limited ãšæŠç¥çææºå¥çŽããã³ã©ããµãŒãã¹å¥çŽãçµãã§ãããElevation Oncology ãšé£æºããŠåºåœ¢è
«çã«ããã NRG1 èåã®ã²ãã æ€æ»ãæ¡å€§ããŠããŸããå瀟㯠2001 幎ã«èšç«ããããããªãå·ãã©ãŒããã€ã€ãŒãºã«æ¬ç€Ÿã眮ããŠããŸãã